Old Web
English
Sign In
Acemap
>
Paper
>
POS-494 An Open label randomized controlled study to evaluate the role of Metformin to retard the progression of ADPKD
POS-494 An Open label randomized controlled study to evaluate the role of Metformin to retard the progression of ADPKD
2021
A. Roy Chaudhary
M. Goswami
D. Sen
Dipankar Sircar
R.M. Pandey
Keywords:
Retard
open label
Metformin
Internal medicine
Randomized controlled trial
Medicine
Oncology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]